SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ALEMBIC PHARMACEUTICALS

BSE: 533573 09 Sep 2025
Healthcare
₹ 958.25
ALEMBIC PHARMACEUTICALS LIMITED specializes in Pharmaceuticals within the Healthcare sector.

ALEMBIC PHARMACEUTICALS - Share Price & Details

Market Cap
₹18,620
High /Low
1,304 / 725.0
Stock P/E
31.4
Book Value
₹264.0
Dividend Yield
1.16
ROCE
13.0
ROE
₹11.4
Face Value
2.0
PEG Ratio
9.87
EVEBITDA
₹18.0
Debt
1,258
CMP / FCF
184.0
Debt to equity
₹0.24
NP Ann
582
High price all time
1,304
Piotroski score
₹5.0
Graham Number
427.0
No. Eq. Shares
19.7
Net CF
₹-36.7
Net profit
601
Price to book value
3.59
Interest Coverage
₹9.16
Low price all time
31.0
Industry PE
33.4
Reserves
₹5,152
Free Cash Flow
₹-466

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
ALEMBIC PHARMACEUTICALS LTD.15019.61035.214941.75.2718,62031.4
NEULAND LABORATORIES LTD.3006.09137.082927.5310.6818410140.0
530019602.058.0595.00.261752236.0

Peer Comparison Chart


About ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS LIMITED, with Security Code 533573, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan

(20 Aug 2025)
Vadodara: Alembic Pharmaceuticals Limited today announced that the company has received final approval from the US Food & Drug...
Read more →

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets

(20 Aug 2025)
Alembic Pharmaceuticals has received final USFDA approval for its Abbreviated New Drug Application (ANDA) of Macitentan Tablets, 10 mg,...
Read more →

Alembic Pharma Gets USFDA Nod for Macitentan Tablets

(20 Aug 2025)
New Delhi, Aug 19 (PTI) Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its...
Read more →

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg

(20 Aug 2025)
Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Read more →

Alembic Pharma Gets USFDA Nod for Tretinoin Cream

(19 Aug 2025)
Alembic Pharmaceuticals has received the green light from the US Food and Drug Administration (USFDA) for its Tretinoin Cream USP, 0.025%.
Read more →

Alembic Pharma Q1FY26 PAT Up 15% YoY to ₹154 Crore

(11 Aug 2025)
Vadodara, August 5, 2025 – Alembic Pharmaceuticals Limited (NSE: APLLTD, BSE: 533573) reported a robust financial performance for Q1FY26.
Read more →

Company Updates